142 related articles for article (PubMed ID: 33957960)
1. Alpha 2-antiplasmin deficiency in a Sudanese child: a case report.
Mohammed BAB
J Med Case Rep; 2021 May; 15(1):238. PubMed ID: 33957960
[TBL] [Abstract][Full Text] [Related]
2. Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.
Aoki N; Saito H; Kamiya T; Koie K; Sakata Y; Kobakura M
J Clin Invest; 1979 May; 63(5):877-84. PubMed ID: 156196
[TBL] [Abstract][Full Text] [Related]
3. Severe hemorrhagic tendency in heterozygous alpha 2-antiplasmin deficiency.
Kordich L; Feldman L; Porterie P; Lago O
Thromb Res; 1985 Dec; 40(5):645-51. PubMed ID: 4089832
[TBL] [Abstract][Full Text] [Related]
4. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin.
Kluft C; Vellenga E; Brommer EJ; Wijngaards G
Blood; 1982 Jun; 59(6):1169-80. PubMed ID: 6177359
[TBL] [Abstract][Full Text] [Related]
5. A bleeding disorder due to deficiency of alpha 2-antiplasmin.
Miles LA; Plow EF; Donnelly KJ; Hougie C; Griffin JH
Blood; 1982 Jun; 59(6):1246-51. PubMed ID: 7082827
[TBL] [Abstract][Full Text] [Related]
6. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
Carpenter SL; Mathew P
Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
[TBL] [Abstract][Full Text] [Related]
7. Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding.
Lijnen HR; Okada K; Matsuo O; Collen D; Dewerchin M
Blood; 1999 Apr; 93(7):2274-81. PubMed ID: 10090937
[TBL] [Abstract][Full Text] [Related]
8. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
[TBL] [Abstract][Full Text] [Related]
9. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
Dewerchin M; Collen D; Lijnen HR
Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
[TBL] [Abstract][Full Text] [Related]
10. Congenital deficiency of alpha 2-plasmin inhibitor in three sisters.
Yoshioka A; Kamitsuji H; Takase T; Iida Y; Tsukada S; Mikami S; Fukui H
Haemostasis; 1982; 11(3):176-84. PubMed ID: 7095605
[TBL] [Abstract][Full Text] [Related]
11. Inherited disorders of the fibrinolytic pathway.
Jain S; Acharya SS
Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
[TBL] [Abstract][Full Text] [Related]
12. Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy.
Takahashi R; Ono K; Ikeda T; Akagi A; Noto D; Nozaki I; Sakai K; Asakura H; Iwasa K; Yamada M
Amyloid; 2012 Sep; 19(3):129-32. PubMed ID: 22624582
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
Nielsen VG
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
[TBL] [Abstract][Full Text] [Related]
14. Quantification of the effects of thrombin activatable fibrinolysis inhibitor and alpha2-antiplasmin on fibrinolysis in normal human plasma.
Nielsen VG; Ellis TC
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):29-33. PubMed ID: 17179823
[TBL] [Abstract][Full Text] [Related]
15. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
16. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
Morishima Y; Honda Y
J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
[TBL] [Abstract][Full Text] [Related]
17. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
Sakata Y; Aoki N
J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014
[TBL] [Abstract][Full Text] [Related]
19. Gene targeting in hemostasis. Alpha2-antiplasmin.
Lijnen HR
Front Biosci; 2001 Feb; 6():D239-47. PubMed ID: 11171550
[TBL] [Abstract][Full Text] [Related]
20. Laboratory evaluation of patients with undiagnosed bleeding disorders.
Alves GS; Orsi FA; Santiago-Bassora FD; Quaino SK; Montalvão SA; Paula EV; Annichino-Bizzacchi JM
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):500-5. PubMed ID: 26825625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
